¡¡
¡¡
¡¡
HOME > ÇÐȸ°£Ç๰ > ¿ë¾î»çÀü
Á¦¸ñ A STUDY ON THE CHANGE OF SERUM ANTI-PGL-I ANTIBODY ACCORDING TO MULTIDRURG THERAPY IN NEW AND RELAPSED MULTIBACILLARY LEPROSY PATIENTS
ÀúÀÚ Sung Jun Choi ¼Ò¼Ó Institute for Leprosy Research, KLCA
³âµµ 1988 ±Ç 21
È£ 1 ¹øÈ£
½ÃÀÛÆäÀÌÁö 35 ³¡ÆäÀÌÁö 42
÷ºÎ
¿ä¾à With ELISA test using ND-O-BSA as antigen, anti-PGL-I IgM antibody titers were
followed up serially for 6 months after initiation of multidrug therapy in 14
multibacillary new patients, 9 relapsed patients, and 118 normal healthy control group
and the following results were obtained.
1. The average anti-PGI-I IgM antibody titer of the new cases was 1.14¡¾0.58
(positive rate: 93%), and that of the relapsed cases was 0.82¡¾0.69 (positive rate :
78%), and their values were significantly higher (P<0.001) than that of normal
control group, 0.035¡¾0.072 (positive rate: 3%).
2. The average antibody titer in patients whose BI were 6+ was 1.30, and in each
patients group with BI 5 ,4 , 3 ,2 , that was 0.92, 0.53, 0.79, and 0.51. Like
this the more the bacterial index increases, the more antibody titers increased in
general.
3. Of 7 ENL cases, there were no significant changes of antibody titers in 4 patients,
but in 3 cases antibody titers decreased significantly after development of ENL.
4. All cases except 2 cases showed no decreasing tendency of antibody titers during
the first 6 months after initiation of multidrug therapy.
³»¿ë
 
¡¡
¡¡
¡¡